Global Prostate Specific Antigen (PSA) Biomarker Market Size, Status and Forecast 2024-2031

Report ID: 934323 | Published Date: Sep 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Blood
        1.2.3 Semen
        1.2.4 Urine
    1.3 Market by Application
        1.3.1 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diagnostics
        1.3.3 Drug Discovery
        1.3.4 Personalized Medicine
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Perspective (2016-2027)
    2.2 Prostate Specific Antigen (PSA) Biomarker Growth Trends by Regions
        2.2.1 Prostate Specific Antigen (PSA) Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Share by Regions (2016-2021)
        2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Regions (2022-2027)
    2.3 Prostate Specific Antigen (PSA) Biomarker Industry Dynamic
        2.3.1 Prostate Specific Antigen (PSA) Biomarker Market Trends
        2.3.2 Prostate Specific Antigen (PSA) Biomarker Market Drivers
        2.3.3 Prostate Specific Antigen (PSA) Biomarker Market Challenges
        2.3.4 Prostate Specific Antigen (PSA) Biomarker Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue
        3.1.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue (2016-2021)
        3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2016-2021)
    3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
    3.4 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
        3.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2020
    3.5 Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Area Served
    3.6 Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
    3.7 Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Type
    4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2016-2021)
    4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2022-2027)

5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application
    5.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Application (2016-2021)
    5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
    6.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type
        6.2.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
        6.2.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
        6.2.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
    6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application
        6.3.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
        6.3.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
        6.3.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
    6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
        6.4.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021)
        6.4.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
    7.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type
        7.2.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
        7.2.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
        7.2.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
    7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application
        7.3.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
        7.3.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
        7.3.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
    7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country
        7.4.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021)
        7.4.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
    8.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type
        8.2.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
    8.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application
        8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
    8.4 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region
        8.4.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
    9.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type
        9.2.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
        9.2.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
        9.2.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
    9.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application
        9.3.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
        9.3.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
        9.3.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
    9.4 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
        9.4.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021)
        9.4.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
    10.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type
        10.2.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
    10.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application
        10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
    10.4 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country
        10.4.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
        11.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 Siemens Healthcare
        11.2.1 Siemens Healthcare Company Details
        11.2.2 Siemens Healthcare Business Overview
        11.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
        11.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.2.5 Siemens Healthcare Recent Development
    11.3 DiaSorin
        11.3.1 DiaSorin Company Details
        11.3.2 DiaSorin Business Overview
        11.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
        11.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.3.5 DiaSorin Recent Development
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
        11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.4.5 Roche Recent Development
    11.5 Tosoh Bioscience
        11.5.1 Tosoh Bioscience Company Details
        11.5.2 Tosoh Bioscience Business Overview
        11.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
        11.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.5.5 Tosoh Bioscience Recent Development
    11.6 Fujirebio
        11.6.1 Fujirebio Company Details
        11.6.2 Fujirebio Business Overview
        11.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
        11.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.6.5 Fujirebio Recent Development
    11.7 BodiTech
        11.7.1 BodiTech Company Details
        11.7.2 BodiTech Business Overview
        11.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
        11.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.7.5 BodiTech Recent Development
    11.8 GE Healthcare
        11.8.1 GE Healthcare Company Details
        11.8.2 GE Healthcare Business Overview
        11.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
        11.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.8.5 GE Healthcare Recent Development
    11.9 Endocare
        11.9.1 Endocare Company Details
        11.9.2 Endocare Business Overview
        11.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
        11.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.9.5 Endocare Recent Development
    11.10 Quest Diagnostics
        11.10.1 Quest Diagnostics Company Details
        11.10.2 Quest Diagnostics Business Overview
        11.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
        11.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.10.5 Quest Diagnostics Recent Development
    11.11 Bio-Rad Laboratories
        11.11.1 Bio-Rad Laboratories Company Details
        11.11.2 Bio-Rad Laboratories Business Overview
        11.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
        11.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.11.5 Bio-Rad Laboratories Recent Development
    11.12 QIAGEN
        11.12.1 QIAGEN Company Details
        11.12.2 QIAGEN Business Overview
        11.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
        11.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.12.5 QIAGEN Recent Development
    11.13 Myriad RBM
        11.13.1 Myriad RBM Company Details
        11.13.2 Myriad RBM Business Overview
        11.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
        11.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
        11.13.5 Myriad RBM Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Blood
    Table 3. Key Players of Semen
    Table 4. Key Players of Urine
    Table 5. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2016-2021)
    Table 9. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2022-2027)
    Table 11. Prostate Specific Antigen (PSA) Biomarker Market Trends
    Table 12. Prostate Specific Antigen (PSA) Biomarker Market Drivers
    Table 13. Prostate Specific Antigen (PSA) Biomarker Market Challenges
    Table 14. Prostate Specific Antigen (PSA) Biomarker Market Restraints
    Table 15. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Players (2016-2021)
    Table 17. Global Top Prostate Specific Antigen (PSA) Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2020)
    Table 18. Ranking of Global Top Prostate Specific Antigen (PSA) Biomarker Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
    Table 22. Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2016-2021)
    Table 26. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Prostate Specific Antigen (PSA) Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Application (2016-2021)
    Table 30. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Abbott Company Details
    Table 63. Abbott Business Overview
    Table 64. Abbott Prostate Specific Antigen (PSA) Biomarker Product
    Table 65. Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 66. Abbott Recent Development
    Table 67. Siemens Healthcare Company Details
    Table 68. Siemens Healthcare Business Overview
    Table 69. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product
    Table 70. Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 71. Siemens Healthcare Recent Development
    Table 72. DiaSorin Company Details
    Table 73. DiaSorin Business Overview
    Table 74. DiaSorin Prostate Specific Antigen (PSA) Biomarker Product
    Table 75. DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 76. DiaSorin Recent Development
    Table 77. Roche Company Details
    Table 78. Roche Business Overview
    Table 79. Roche Prostate Specific Antigen (PSA) Biomarker Product
    Table 80. Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 81. Roche Recent Development
    Table 82. Tosoh Bioscience Company Details
    Table 83. Tosoh Bioscience Business Overview
    Table 84. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product
    Table 85. Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 86. Tosoh Bioscience Recent Development
    Table 87. Fujirebio Company Details
    Table 88. Fujirebio Business Overview
    Table 89. Fujirebio Prostate Specific Antigen (PSA) Biomarker Product
    Table 90. Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 91. Fujirebio Recent Development
    Table 92. BodiTech Company Details
    Table 93. BodiTech Business Overview
    Table 94. BodiTech Prostate Specific Antigen (PSA) Biomarker Product
    Table 95. BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 96. BodiTech Recent Development
    Table 97. GE Healthcare Company Details
    Table 98. GE Healthcare Business Overview
    Table 99. GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 100. GE Healthcare Recent Development
    Table 101. Endocare Company Details
    Table 102. Endocare Business Overview
    Table 103. Endocare Prostate Specific Antigen (PSA) Biomarker Product
    Table 104. Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 105. Endocare Recent Development
    Table 106. Quest Diagnostics Company Details
    Table 107. Quest Diagnostics Business Overview
    Table 108. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product
    Table 109. Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 110. Quest Diagnostics Recent Development
    Table 111. Bio-Rad Laboratories Company Details
    Table 112. Bio-Rad Laboratories Business Overview
    Table 113. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product
    Table 114. Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 115. Bio-Rad Laboratories Recent Development
    Table 116. QIAGEN Company Details
    Table 117. QIAGEN Business Overview
    Table 118. QIAGEN Prostate Specific Antigen (PSA) Biomarker Product
    Table 119. QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 120. QIAGEN Recent Development
    Table 121. Myriad RBM Company Details
    Table 122. Myriad RBM Business Overview
    Table 123. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product
    Table 124. Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
    Table 125. Myriad RBM Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Type: 2020 VS 2027
    Figure 2. Blood Features
    Figure 3. Semen Features
    Figure 4. Urine Features
    Figure 5. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2020 VS 2027
    Figure 6. Diagnostics Case Studies
    Figure 7. Drug Discovery Case Studies
    Figure 8. Personalized Medicine Case Studies
    Figure 9. Others Case Studies
    Figure 10. Prostate Specific Antigen (PSA) Biomarker Report Years Considered
    Figure 11. Global Prostate Specific Antigen (PSA) Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Prostate Specific Antigen (PSA) Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions: 2020 VS 2027
    Figure 14. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2022-2027)
    Figure 15. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Players in 2020
    Figure 16. Global Top Prostate Specific Antigen (PSA) Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue in 2020
    Figure 18. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2016-2021)
    Figure 19. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2022-2027)
    Figure 20. North America Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
    Figure 22. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
    Figure 23. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2016-2027)
    Figure 24. United States Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
    Figure 28. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
    Figure 29. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2016-2027)
    Figure 30. Germany Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Share by Region (2016-2027)
    Figure 40. China Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
    Figure 48. Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
    Figure 49. Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2016-2027)
    Figure 50. Mexico Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2016-2027)
    Figure 56. Turkey Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Abbott Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 60. Siemens Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 61. DiaSorin Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 63. Tosoh Bioscience Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 64. Fujirebio Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 65. BodiTech Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 66. GE Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 67. Endocare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 68. Quest Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 70. QIAGEN Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 71. Myriad RBM Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Siemens Healthcare
DiaSorin
Roche
Tosoh Bioscience
Fujirebio
BodiTech
GE Healthcare
Endocare
Quest Diagnostics
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Frequently Asked Questions
Prostate Specific Antigen (PSA) Biomarker report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Specific Antigen (PSA) Biomarker report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Specific Antigen (PSA) Biomarker report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports